Aviva’s St Jude Medical STJ Stock Holding History
Bought
Maintained
Sold
Other funds holding STJ
FPF
JWA
AIM
Aviva's STJ Position: Q1 2017 in Review
Aviva sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 185,309 shares — an estimated $14.9M sold.
Aviva first reported a position in STJ in Q2 2013 and held it in 15 quarters. The position peaked at $14.9M in Q4 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.
- Aviva reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
- Aviva sold 185,309 St Jude Medical shares in Q1 2017, an estimated $14.9M.
- Aviva first reported a position in St Jude Medical in Q2 2013 and held it in 15 quarters.
- Aviva's St Jude Medical position peaked at $14.9M in Q4 2016.
- 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.
Based on Aviva's 13F filing for Q1 2017, filed 15 May 2017.